A Randomized, Active Controlled, Parallel Group, Multicentre, Two-Phase, Open-Label Study Comparing the Safety and Immunogenicity of Insugen R and Insugen N with Actrapid and Insulatard in Patients with Type 1 Diabetes Mellitus
100 Clinical Results associated with Biocon SA
0 Patents (Medical) associated with Biocon SA
100 Deals associated with Biocon SA
100 Translational Medicine associated with Biocon SA